Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-11-25

Clinical Trial Update: Clinical Trial to Evaluate the Bioavailability and Safety of AGSAV301 [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the bioavailability and safety of AGSAV301 has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AGSAV301

Snippet

Sponsor: Ahn-Gook Pharmaceuticals Co.,Ltd | Conditions: Hypertension | Phase 1 | Status: COMPLETED